Despite the multitude of antidepressant options available, most depressed patients fail to achieve remission even with adequate antidepressant monotherapy. Treatment-resistant depression continues to be a major and increasing healthcare burden. What is the role of the clinical pharmacist in guiding depression treatment? Treatment strategies should be evidence-based and tailored to the individual patient through the systematic measurement of symptom resolution, adverse effects, and patient functioning. Clinical pharmacists are influential in promoting safe and effective pharmaceutical care. Using their extensive knowledge of pharmacotherapeutic options along with the most recent evidence-based clinical treatment guidelines, pharmacists are able to identify, recommend, and monitor various pharmacotherapeutic strategies to optimize patient outcomes in treatment-resistant depression.
This CE activity is intended for pharmacists and other healthcare professionals who have an interest in identifying and managing psychiatric patients with treatment resistant depression.
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE provider number is 0447-9999-09-084-H04-P. To receive 2 contact hours of continuing education credit, 0.2 Continuing Education Units (CEUs), pharmacists need to complete the activity requirements at the conclusion of the activity.